Influenza A antibody Avian antibody H5N1 antibody CT antibody Neuraminidase (NA) Control petide (Bird Flu) - Blocking Peptide

Many awards

The Blocking Peptides we offer receive many awards.

Best practices

Systematic production of Activating Antibody ensuring their high quality.

Big trust

To this day, many customers have trusted us and our Antibody products.

Size

50 μg

Catalog no.

X2576B

Price

278 EUR

 

Details

Storage

-20ºC

Tissue

control

Protein number

see ncbi

French translation

anticorps

Virus

influenza

Antibody is raised in

see techfile

Antibody's reacts with

see techfile

Clone

not specified

Application

ELISA, BLOCKING

Antibody's specificity

No Data Available

Relevant references

no information yet

Category

Proteins & Peptides

Antibody come from

Purified avian influenza virus type A (H5N1)

Antibody's reacts with these species

This antibody doesn't cross react with other species

Antibody's suited for

Optimal concentration should be evaluated by serial dilutions.

Other description

Supplied as a liquid in PBS, pH 7.4, 0.1% sodium azide. Purified

Test

You can block the antibody by the specific target amino acid sequence of peptide.

Antigen-antibody binding interaction

Influenza A antibody Avian antibody H5N1 antibody CT antibody Neuraminidase (NA) Control petide (Bird Flu) - Blocking Peptide

Properties

If you buy Antibodies supplied by nordc they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.Influenza A antibody Avian antibody H5N1 antibody CT antibody Neuraminidase (NA) Control petide ( Flu) - Blocking Peptide works on aves samples.blocking peptide

Warnings

This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.

Long description

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus.

Description

Isotype or positive controls by peptides, antibodies and deactivated samples.Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.